Miami Membrane for Potency (MMEP) Trial

Stopped early · Phase 2

Conditions studied: Prostate Cancer

In brief

The use of dehydrated human amnionic membrane allograft improves erectile function recovery (as measured by (Sexual History Inventory for Men (SHIM) score) at 12 months after robotic assisted radical prostatectomy (RARP) compared to a control group with no allograft.

Key facts

Study ID

NCT02710422

Run by

University of Miami

People needed

24

Starts

2016-05-17

Expected to finish

2019-01-22

Last updated by the study team

2019-09-11

Who can join

Age: 40 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Men age 40-80 with localized prostate cancer who are undergoing bilateral nerve sparing RARP at the University of Miami

You may not qualify if…

• Men with poor urinary control at baseline requiring the use of pads for leakage
• Previous treatment for prostate cancer
• Previous history of pelvic radiation
• Men who are using non-oral erectile aids such as vacuum pump, intra-cavernous injections, MUSE, penile prosthesis.

Where it is running

• University of Miami — Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.